Manufacturer record
Pondchy Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Pondchy Pharmaceuticals (Puducherry) were declared Not of Standard Quality between December 2024 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Pondchy Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Glimepiride Tablets IP 1mg | PGG24-012Mfg 2024-08 · Exp 2026-07 | Sample does not conform to IP specification for Glimepiride Tablets with respect to DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | May 2025 |
| Amoxycillin Dispersible Tablets IP 125 mg | PGA24- 001Mfg 2024-01 · Exp 2025-12 | Sample does not conform to IP Specification for Dispersible Tablets with respect to uniformity of Dispersion and DisintegrationDisintegration | DTL ChennaiState lab | Jan 2025 |
| Amoxycillin Dispersible Tablets IP 125 mg | PGA24- 006Mfg 2024-08 · Exp 2026-07 | Sample does not conform to IP Specification for Dispersible Tablets with respect to uniformity of Dispersion and DisintegrationDisintegration | DTL ChennaiState lab | Jan 2025 |
| Glimepiride Tablets IP 1mg | PGG24- 002Mfg 2024-06 · Exp 2026-05 | Sample does not conform to IP specification for Glimepiride Tablets with respect to Dissolution.Dissolution | DTL ChennaiState lab | Dec 2024 |
| Amoxycillin Dispersible Tablets IP 125 mg | PGA24- 002Mfg 2024-03 · Exp 2026-02 | Sample does not conform to IP Specification for Dispersible Tablets with respect to uniformity of Dispersion and DisintegrationDisintegration | DTL ChennaiState lab | Dec 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.